Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?

Cell cycle (Georgetown, Tex.) - 1 Jan 2021

Abedi Farshad, Rezaee Ramin, Hayes A Wallace, Nasiripour Somayyeh, Karimi Gholamreza

Abstract excerpt

To date, proposed therapies and antiviral drugs have been failed to cure coronavirus disease 2019 (COVID-19) patients. However, at least two drug companies have applied for emergency use authorization with the United States Food and Drug Administration for their coronavirus vaccine candidates and several other vaccines are in various stages of development to determine safety and efficacy. Recently, some studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Biomarkers
Share to Cell Cycle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Drug Treatment

Share to COVID-19 Vaccines

Share to MicroRNAs

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33382348
DOI: 10.1080/15384101.2020.1867792
PMCID: PMC7889196

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?PMID 33382348Read ↗

The Role of miRNAs in COVID-19 DiseaseSemantic proximity Read ↗

Role of microRNAs in COVID-19 with implications for therapeuticsSemantic proximity Read ↗

Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host CellsSemantic proximity Read ↗

The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.Semantic proximity Read ↗

The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A reviewSemantic proximity Read ↗

Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and TherapySemantic proximity Read ↗

Role of Mirnas As Biomarkers of Covid-19: A Scoping Review of the Status and Future Directions for Research in This FieldSemantic proximity Read ↗

SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infectionSemantic proximity Read ↗

The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infectionSemantic proximity Read ↗

SARS-CoV-2 Produces a microRNA, CoV2-miR-O8, in Patients with COVID-19 InfectionSemantic proximity Read ↗

The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSemantic proximity Read ↗

A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.